Eligible MOC CPD credits: Up to 1.75 Section 3 Self-Assessment Program hours
The BCRS is pleased to bring you a multidisciplinary session on Rectal Cancer Staging and Reporting.
The course includes:
- Introduction to Rectal Cancer Imaging and MRI Technique
- MRI Staging and Template: New diagnosis
- Different Treatment Options: What the Oncologist Needs to Know
- Different Treatment Options: What the Surgeon Needs to Know
- MRI Staging and Template: Post treatment
- Interactive Case Review
Are you a BCRS Member?
To receive your CME pricing discount login below:
Moderated by Dr. Silvia Chang, BCRS Programs Chair, the speakers secured to date include (in alphabetical order):
Dr. Carl Brown, Colorectal Surgeon – Providence Health Care
Dr. Cameron Hague, Radiologist – Providence Health Care
Dr. Timothy Murray, Radiologist – Providence Health Care
Dr. Michael Peacock. Radiation Oncologist – BC Cancer Vancouver
Dr. Pari Tiwari, Radiologist – Providence Health Care
Dr. Patrick Vos, Radiologist – Providence Health Care
Materials to be included with the Case Review video include Rectal Cancer Staging and Reporting Templates and Protocols and the others in the Materials folder, eg.
- SAR Primary Rectal Cancer Staging Template – v.2020
- MRI pelvis Rectal Cancer Restaging Template
The University of British Columbia Division of Continuing Professional Development (UBC CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide study credits for continuing medical education for physicians. This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program (MOC) of the Royal College of Physicians and Surgeons of Canada and has been approved by UBC CPD for up to 1.75 MOC Section 3 Self-Assessment hours (credits are automatically calculated). Each physician should claim only those credits accrued through participation in the activity. SAP ID: 00014528 MOC Section 3 accreditation is good for three years and expires on June 7, 2025.
Photo: Cancer Research UK | Wikimedia Commons